These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 35116947)

  • 1. DNA hypermethylation of
    Liu X; Bi H; Ge A; Xia T; Fu J; Liu Y; Sun H; Li D; Zhao Y
    Transl Cancer Res; 2019 Sep; 8(5):1985-1996. PubMed ID: 35116947
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA methylation of SFRP1, SFRP2, and WIF1 and prognosis of postoperative colorectal cancer patients.
    Liu X; Fu J; Bi H; Ge A; Xia T; Liu Y; Sun H; Li D; Zhao Y
    BMC Cancer; 2019 Dec; 19(1):1212. PubMed ID: 31830937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TFAP2E hypermethylation was associated with survival advantage in patients with colorectal cancer.
    Zhang ZM; Wang Y; Huang R; Liu YP; Li X; Hu FL; Zhu L; Wang F; Cui BB; Dong XS; Zhao YS
    J Cancer Res Clin Oncol; 2014 Dec; 140(12):2119-27. PubMed ID: 24996990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mapping of DNA Hypermethylation and Hypomethylation induced by Folate Deficiency in Sporadic Colorectal Cancer and Clinical Implication Analysis of Hypermethylation Pattern in CBS Promoter.
    Zhang Z; He Y; Tu X; Huang S; Chen Z; Wang L; Song J
    Clin Lab; 2017 Apr; 63(4):733-748. PubMed ID: 28397458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PBX3 hypermethylation in peripheral blood leukocytes predicts better prognosis in colorectal cancer: A propensity score analysis.
    Sun H; Huang H; Li D; Zhang L; Zhang Y; Xu J; Liu Y; Liu Y; Zhao Y
    Cancer Med; 2019 Jul; 8(8):4001-4011. PubMed ID: 31140752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential DNA methylation analysis of
    Su JQ; Lai PY; Hu PH; Hu JM; Chang PK; Chen CY; Wu JJ; Lin YJ; Sun CA; Yang T; Hsu CH; Lin HC; Chou YC
    World J Gastroenterol; 2022 Feb; 28(8):825-839. PubMed ID: 35317099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA hypermethylation and decreased mRNA expression of MAL, PRIMA1, PTGDR and SFRP1 in colorectal adenoma and cancer.
    Kalmár A; Péterfia B; Hollósi P; Galamb O; Spisák S; Wichmann B; Bodor A; Tóth K; Patai ÁV; Valcz G; Nagy ZB; Kubák V; Tulassay Z; Kovalszky I; Molnár B
    BMC Cancer; 2015 Oct; 15():736. PubMed ID: 26482433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aberrant DNA methylation profiles of inherited and sporadic colorectal cancer.
    Sahnane N; Magnoli F; Bernasconi B; Tibiletti MG; Romualdi C; Pedroni M; Ponz de Leon M; Magnani G; Reggiani-Bonetti L; Bertario L; Signoroni S; Capella C; Sessa F; Furlan D;
    Clin Epigenetics; 2015; 7():131. PubMed ID: 26697123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Relevance of Plasma DNA Methylation in Colorectal Cancer Patients Identified by Using a Genome-Wide High-Resolution Array.
    Lin PC; Lin JK; Lin CH; Lin HH; Yang SH; Jiang JK; Chen WS; Chou CC; Tsai SF; Chang SC
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1419-27. PubMed ID: 25472652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genome-Wide Methylation Profiling of lncRNAs Reveals a Novel Progression-Related and Prognostic Marker for Colorectal Cancer.
    Lin S; Gu S; Qian S; Liu Y; Sheng J; Li Q; Yang J; Ying X; Li Z; Tang M; Wang J; Chen K; Jin M
    Front Oncol; 2021; 11():782077. PubMed ID: 35127488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin-like growth factor 2 hypermethylation in peripheral blood leukocytes and colorectal cancer risk and prognosis: a propensity score analysis.
    Sun H; Liu Y; Zhang Y; Wang Y; Zhao Y; Liu Y
    Front Oncol; 2023; 13():971435. PubMed ID: 37213278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aberrant methylated EDNRB can act as a potential diagnostic biomarker in sporadic colorectal cancer while KISS1 is controversial.
    Mousavi Ardehaie R; Hashemzadeh S; Behrouz Sharif S; Ghojazadeh M; Teimoori-Toolabi L; Sakhinia E
    Bioengineered; 2017 Sep; 8(5):555-564. PubMed ID: 28140749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p16INK4a gene promoter hypermethylation in mucosa as a prognostic factor for patients with colorectal cancer.
    Wettergren Y; Odin E; Nilsson S; Carlsson G; Gustavsson B
    Mol Med; 2008; 14(7-8):412-21. PubMed ID: 18418463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA Hypermethylation of SHISA3 in Colorectal Cancer: An Independent Predictor of Poor Prognosis.
    Tsai MH; Chen WC; Yu SL; Chen CC; Jao TM; Huang CY; Tzeng ST; Yen SJ; Yang YC
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1481-9. PubMed ID: 25968618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NKX6.1 hypermethylation predicts the outcome of stage II colorectal cancer patients undergoing chemotherapy.
    Chang SY; Kuo CC; Wu CC; Hsiao CW; Hu JM; Hsu CH; Chou YC; Shih YL; Lin YW
    Genes Chromosomes Cancer; 2018 May; 57(5):268-277. PubMed ID: 29363224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Eps15 Homology Domain-Containing Protein 3 Hypermethylation as a Prognostic and Predictive Marker for Colorectal Cancer.
    Wang YH; Chang SC; Ansar M; Hung CS; Lin RK
    Biomedicines; 2021 Apr; 9(5):. PubMed ID: 33922189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IGFBP3 methylation is a novel diagnostic and predictive biomarker in colorectal cancer.
    Perez-Carbonell L; Balaguer F; Toiyama Y; Egoavil C; Rojas E; Guarinos C; Andreu M; Llor X; Castells A; Jover R; Boland CR; Goel A
    PLoS One; 2014; 9(8):e104285. PubMed ID: 25127039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic Values of EPDR1 Hypermethylation and Its Inhibitory Function on Tumor Invasion in Colorectal Cancer.
    Chu CH; Chang SC; Wang HH; Yang SH; Lai KC; Lee TC
    Cancers (Basel); 2018 Oct; 10(10):. PubMed ID: 30360391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Androgen receptor gene methylation related to colorectal cancer risk.
    Xia T; Sun H; Huang H; Bi H; Pu R; Zhang L; Zhang Y; Liu Y; Xu J; Onwuka JU; Liu Y; Cui B; Zhao Y
    Endocr Connect; 2019 Jul; 8(7):979-987. PubMed ID: 31176300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypermethylation and decreased expression of TMEM240 are potential early-onset biomarkers for colorectal cancer detection, poor prognosis, and early recurrence prediction.
    Chang SC; Liew PL; Ansar M; Lin SY; Wang SC; Hung CS; Chen JY; Jain S; Lin RK
    Clin Epigenetics; 2020 May; 12(1):67. PubMed ID: 32398064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.